BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30243646)

  • 21. Integrative analysis to identify oncogenic gene expression changes associated with copy number variations of enhancer in ovarian cancer.
    Li X; Liu Y; Lu J; Zhao M
    Oncotarget; 2017 Oct; 8(53):91558-91567. PubMed ID: 29207666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
    Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
    Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel.
    Yan K; Niu L; Wu B; He C; Deng L; Chen C; Lan Z; Lin C; Kuang W; Lin H; Zou J; Zhang W; Luo Z
    Ann Med; 2023; 55(2):2280708. PubMed ID: 37967237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
    Yan Y; Gao R; Trinh TLP; Grant MB
    Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
    [No Abstract]   [Full Text] [Related]  

  • 25. A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes.
    Newton R; Wernisch L
    PLoS One; 2019; 14(7):e0213221. PubMed ID: 31335867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
    Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
    Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Sparse Learning Framework for Joint Effect Analysis of Copy Number Variants.
    Wang Z; Hall B; Xu J; Shi X
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(5):1013-1027. PubMed ID: 28991724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA.
    Kechavarzi BD; Wu H; Doman TN
    PLoS One; 2019; 14(1):e0210910. PubMed ID: 30653567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copy number loss or silencing of apoptosis-effector genes in cancer.
    Mauro JA; Butler SN; Ramsamooj M; Blanck G
    Gene; 2015 Jan; 554(1):50-7. PubMed ID: 25307873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
    Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
    Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
    Wang G; Anastassiou D
    Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer gene prioritization by integrative analysis of mRNA expression and DNA copy number data: a comparative review.
    Lahti L; Schäfer M; Klein HU; Bicciato S; Dugas M
    Brief Bioinform; 2013 Jan; 14(1):27-35. PubMed ID: 22441573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of genomics in melanoma oncogene discovery.
    Berger MF; Garraway LA
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):397-414, vii. PubMed ID: 19464593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of consistent post-translational regulatory triplets related to oncogenic and tumour suppressive modulators in childhood acute lymphoblastic leukemia.
    Wee Y; Liu Y; Zhao M
    PeerJ; 2021; 9():e11803. PubMed ID: 34316412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the copy number variant biomarkers for breast cancer subtypes.
    Pan X; Hu X; Zhang YH; Chen L; Zhu L; Wan S; Huang T; Cai YD
    Mol Genet Genomics; 2019 Feb; 294(1):95-110. PubMed ID: 30203254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of cancer associated genes revealed by modern univariate and multivariate association tests.
    Gorfine M; Goldstein B; Fishman A; Heller R; Heller Y; Lamm AT
    PLoS One; 2015; 10(5):e0126544. PubMed ID: 25965968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of cancers based on copy number variation landscapes.
    Zhang N; Wang M; Zhang P; Huang T
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2750-5. PubMed ID: 27266344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
    Shen W; Szankasi P; Sederberg M; Schumacher J; Frizzell KA; Gee EP; Patel JL; South ST; Xu X; Kelley TW
    Br J Haematol; 2016 Apr; 173(1):49-58. PubMed ID: 26728869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pitfalls in experimental designs for characterizing the transcriptional, methylational and copy number changes of oncogenes and tumor suppressor genes.
    Zhang Y; Xia J; Zhang Y; Qin Y; Yang D; Qi L; Zhao W; Wang C; Guo Z
    PLoS One; 2013; 8(3):e58163. PubMed ID: 23472150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.